2020 US Tumor Marker Testing Analyzers and Reagents: Supplier Shares and Strategies, Volume and Sales Segment Forecasts by Product--Competitive Profiles, Technology and Instrumentation Review, Opportunities for Suppliers

NEW YORK, Feb. 4, 2020 /PRNewswire/ --

2020 US Tumor Marker Testing Analyzers and Reagents: Supplier Shares and Strategies, Volume and Sales Segment Forecasts by Product--Competitive Profiles, Technology and Instrumentation Review, Opportunities for Suppliers

Read the full report: https://www.reportlinker.com/p05843838/?utm_source=PRN

Highlights

    --  Comprehensive 620-page analysis of the US tumor marker testing market.
    --  Major issues pertaining to the US laboratory practice, as well as key
        economic, regulatory, demographic, social and technological trends with
        significant market impact during the next five years.
    --  Mortality statistics and scientific views on the etiology of major types
        of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic,
        leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian,
        testicular, oral, skin and others.
    --  Five-year test volume and sales forecasts over for 40 tumor marker
        performed in US hospitals, commercial laboratories and physician
        offices.
    --  Placements and installed base of automated and semi-automated analyzers
        used for tumor marker testing.
    --  Current instrumentation technologies and feature comparison of leading
        analyzers.
    --  Sales and market shares of leading suppliers.
    --  Emerging diagnostic technologies and their potential market
        applications.
    --  Product development opportunities.
    --  Profiles of current and emerging suppliers, including their sales,
        market shares, product portfolios, marketing tactics, technological
        know-how, new products in RandD, collaborative arrangements and business
        strategies.
    --  Business opportunities and strategic recommendations for suppliers.

Contains 620 pages and 103 tables

Companies Profiled
Competitive Assessments

- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- GSK Biologicals
- Hologic
- Leica Biosystems
- Lonza
- Ortho-Clinical Diagnostics
- PerkinElmer
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens Healthineers
- Takara Bio
- Thermo Fisher
- Wako


Read the full report: https://www.reportlinker.com/p05843838/?utm_source=PRN

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

View original content:http://www.prnewswire.com/news-releases/2020-us-tumor-marker-testing-analyzers-and-reagents-supplier-shares-and-strategies-volume-and-sales-segment-forecasts-by-product--competitive-profiles-technology-and-instrumentation-review-opportunities-for-suppliers-300998349.html

SOURCE Reportlinker